Frontiers in Anti-Infective Drug Discovery Volume 3

By Atta-ur-Rahman, FRS

Infectious diseases are slowly becoming a major threat to human survival. Many people predict the return of the pre-antibiotic period due to the emergence of resistance against all major classes of antibiotics. It is now more difficult to treat infectious diseases than it was in the last several decades. Super-bugs, XRDs and TRDs, now result in more deaths than ever before. Many nosocomial infections are now spread in communities, largely affecting the malnourished populations, living in poor hygienic conditions in densely populated regions of the world. Difficulty in treating infections is directly affecting the outcome of surgical intervention, pre-mature birth, and hospital care of elderly and immune compromised patients. The dwindling supply of effective medicines against  prevailing infectious diseases is yet another challenge, as fewer and fewer pharmaceutical companies are interested to work in this field due to economic reasons. Yet fortunately academic and research communities continue to work towards understanding the infectious diseases and resistance in positive agents at the molecular level. The scientific literature is constantly being enriched with
useful information and seminal discoveries. This is where we feel the eBook series such as the “Frontier in Anti-Infective Drug Discovery” can play an important role in updating the scientific community and providing them with an overview of key recent findings.

Volume 3 of the eBook series entitled, “Frontiers in Anti-Infective Drug Discovery”, is a useful compilation of six scholarly reviews, contributed by some of the most eminent researchers in the field. We expect this volume to be a useful treatise for researchers interested in infections and their treatments.


This content is for gold members only. Log In or Register to see
Tags: , ,

Comments are closed.